Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
13.75
-0.83 (-5.69%)
At close: Sep 11, 2024, 4:00 PM
13.62
-0.13 (-0.95%)
After-hours: Sep 11, 2024, 4:34 PM EDT
Centessa Pharmaceuticals Employees
Centessa Pharmaceuticals had 76 employees as of December 31, 2023. The number of employees decreased by 7 or -8.43% compared to the previous year.
Employees
76
Change (1Y)
-7
Growth (1Y)
-8.43%
Revenue / Employee
$90,171
Profits / Employee
-$2,070,355
Market Cap
1.56B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 76 | -7 | -8.43% |
Dec 31, 2022 | 83 | -7 | -7.78% |
Dec 31, 2021 | 90 | - | - |
Related Stocks
Company Name | Employees |
---|---|
AMN Healthcare Services | 3,585 |
Warby Parker | 3,473 |
Arcus Biosciences | 577 |
BioCryst Pharmaceuticals | 536 |
Immunocore Holdings | 497 |
MannKind | 414 |
Kiniksa Pharmaceuticals International, | 297 |
Nurix Therapeutics | 284 |
CNTA News
- 49 minutes ago - Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares - GlobeNewsWire
- 10 hours ago - Nxera Pharma's Partner Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers - GlobeNewsWire
- 1 day ago - Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers - GlobeNewsWire
- 15 days ago - Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024) - GlobeNewsWire
- 21 days ago - Centessa Pharmaceuticals to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024 - GlobeNewsWire
- 3 months ago - Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as Chief Financial Officer and Gregory Weinhoff MD MBA, as Chief Business Officer - GlobeNewsWire
- 4 months ago - Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire